MedTrace Logo

Effect of Acetyl-L-carnitine on Chronic Pancreatitis

NCT02538146 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-03-10

No results posted yet for this study

Summary

An open label pilot study will determine the effect of the amino acid nutritional supplement acetyl-L-carnitine (ALC) on pain, quality of life, well-being, and serum pro-inflammatory mediator and oxidative stress levels in volunteers with chronic pancreatitis. The ALC is given to all participants for 3 months, and assessments will occur at intake and after 3 months.

Conditions

  • Chronic Pancreatitis

Interventions

DIETARY_SUPPLEMENT

acetyl-L-carnitine 1000mg 2X per day for 3 months

non-essential dietary amino acid

Sponsors & Collaborators

  • University of Kentucky

    collaborator OTHER

  • Karin High

    lead OTHER

Principal Investigators

  • Karin W High, PhD · University of Kentucky

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02538146 on ClinicalTrials.gov